Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells

Eduardo F. Farias, Kevin Petrie, Boris Leibovitch, Janice Murtagh, Manuel Boix Chornet, Tino Schenk, Arthur Z Zelent, Samuel Waxmana

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Sin3A/B is amaster transcriptional scaffold andcorepressor that plays an essential role in the regulation of gene transcription and maintenance of chromatin structure, and its inappropriate recruitment has been associated with aberrant gene silencing in cancer. Sin3A/B are highly related, large, multidomian proteins that interact with a wide variety of transcription factors and corepressor components, andwe examined whether disruption of the function of a specific domain could lead to epigenetic reprogramming and derepression of specific subsets of genes. To this end, we selected the Sin3A/B-paired amphipathic α-helices (PAH2) domain based on its established role in mediating the effects of a relatively small number of transcription factors containing a PAH2-binding motif known as the Sin3 interaction domain (SID). Here, we show that in both human and mouse breast cancer cells, the targeted disruption of Sin3 function by introduction of a SID decoy that interferes with PAH2 binding to SID-containing partner proteins reverted the silencing of genes involved in cell growth and differentiation. In particular, the SID decoy led to epigenetic reprogramming and reexpression of the important breast cancer-associated silenced genes encoding E-cadherin, estrogen receptor α, and retinoic acid receptor β and impaired tumor growth in vivo. Interestingly, the SID decoy was effective in the triple-negative M.D. Anderson-Metastatic Breast-231 (MDA-MB-231) breast cancer cell line, restoring sensitivity to 17β-estradiol, tamoxifen, and retinoids. Therefore, the development of small molecules that can block interactions between PAH2 and SID-containing proteins offers a targeted epigenetic approach for treating this type of breast cancer that may also have wider therapeutic implications.

Original languageEnglish (US)
Pages (from-to)11811-11816
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume107
Issue number26
DOIs
StatePublished - Jun 29 2010
Externally publishedYes

Fingerprint

Epigenomics
Breast Neoplasms
Gene Silencing
Transcription Factors
Protein Interaction Domains and Motifs
Genes
Co-Repressor Proteins
Retinoic Acid Receptors
Retinoids
Cadherins
Tamoxifen
Growth
Estrogen Receptors
Chromatin
Cell Differentiation
Estradiol
Neoplasms
Proteins
Breast
Maintenance

Keywords

  • E-cadherin
  • Estrogen receptor
  • Sin3 interaction domain
  • Triple-negative

ASJC Scopus subject areas

  • General

Cite this

Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells. / Farias, Eduardo F.; Petrie, Kevin; Leibovitch, Boris; Murtagh, Janice; Chornet, Manuel Boix; Schenk, Tino; Zelent, Arthur Z; Waxmana, Samuel.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, No. 26, 29.06.2010, p. 11811-11816.

Research output: Contribution to journalArticle

Farias, Eduardo F. ; Petrie, Kevin ; Leibovitch, Boris ; Murtagh, Janice ; Chornet, Manuel Boix ; Schenk, Tino ; Zelent, Arthur Z ; Waxmana, Samuel. / Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells. In: Proceedings of the National Academy of Sciences of the United States of America. 2010 ; Vol. 107, No. 26. pp. 11811-11816.
@article{31d87b1ffa00417d97332c919f3bc52d,
title = "Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells",
abstract = "Sin3A/B is amaster transcriptional scaffold andcorepressor that plays an essential role in the regulation of gene transcription and maintenance of chromatin structure, and its inappropriate recruitment has been associated with aberrant gene silencing in cancer. Sin3A/B are highly related, large, multidomian proteins that interact with a wide variety of transcription factors and corepressor components, andwe examined whether disruption of the function of a specific domain could lead to epigenetic reprogramming and derepression of specific subsets of genes. To this end, we selected the Sin3A/B-paired amphipathic α-helices (PAH2) domain based on its established role in mediating the effects of a relatively small number of transcription factors containing a PAH2-binding motif known as the Sin3 interaction domain (SID). Here, we show that in both human and mouse breast cancer cells, the targeted disruption of Sin3 function by introduction of a SID decoy that interferes with PAH2 binding to SID-containing partner proteins reverted the silencing of genes involved in cell growth and differentiation. In particular, the SID decoy led to epigenetic reprogramming and reexpression of the important breast cancer-associated silenced genes encoding E-cadherin, estrogen receptor α, and retinoic acid receptor β and impaired tumor growth in vivo. Interestingly, the SID decoy was effective in the triple-negative M.D. Anderson-Metastatic Breast-231 (MDA-MB-231) breast cancer cell line, restoring sensitivity to 17β-estradiol, tamoxifen, and retinoids. Therefore, the development of small molecules that can block interactions between PAH2 and SID-containing proteins offers a targeted epigenetic approach for treating this type of breast cancer that may also have wider therapeutic implications.",
keywords = "E-cadherin, Estrogen receptor, Sin3 interaction domain, Triple-negative",
author = "Farias, {Eduardo F.} and Kevin Petrie and Boris Leibovitch and Janice Murtagh and Chornet, {Manuel Boix} and Tino Schenk and Zelent, {Arthur Z} and Samuel Waxmana",
year = "2010",
month = "6",
day = "29",
doi = "10.1073/pnas.1006737107",
language = "English (US)",
volume = "107",
pages = "11811--11816",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "26",

}

TY - JOUR

T1 - Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells

AU - Farias, Eduardo F.

AU - Petrie, Kevin

AU - Leibovitch, Boris

AU - Murtagh, Janice

AU - Chornet, Manuel Boix

AU - Schenk, Tino

AU - Zelent, Arthur Z

AU - Waxmana, Samuel

PY - 2010/6/29

Y1 - 2010/6/29

N2 - Sin3A/B is amaster transcriptional scaffold andcorepressor that plays an essential role in the regulation of gene transcription and maintenance of chromatin structure, and its inappropriate recruitment has been associated with aberrant gene silencing in cancer. Sin3A/B are highly related, large, multidomian proteins that interact with a wide variety of transcription factors and corepressor components, andwe examined whether disruption of the function of a specific domain could lead to epigenetic reprogramming and derepression of specific subsets of genes. To this end, we selected the Sin3A/B-paired amphipathic α-helices (PAH2) domain based on its established role in mediating the effects of a relatively small number of transcription factors containing a PAH2-binding motif known as the Sin3 interaction domain (SID). Here, we show that in both human and mouse breast cancer cells, the targeted disruption of Sin3 function by introduction of a SID decoy that interferes with PAH2 binding to SID-containing partner proteins reverted the silencing of genes involved in cell growth and differentiation. In particular, the SID decoy led to epigenetic reprogramming and reexpression of the important breast cancer-associated silenced genes encoding E-cadherin, estrogen receptor α, and retinoic acid receptor β and impaired tumor growth in vivo. Interestingly, the SID decoy was effective in the triple-negative M.D. Anderson-Metastatic Breast-231 (MDA-MB-231) breast cancer cell line, restoring sensitivity to 17β-estradiol, tamoxifen, and retinoids. Therefore, the development of small molecules that can block interactions between PAH2 and SID-containing proteins offers a targeted epigenetic approach for treating this type of breast cancer that may also have wider therapeutic implications.

AB - Sin3A/B is amaster transcriptional scaffold andcorepressor that plays an essential role in the regulation of gene transcription and maintenance of chromatin structure, and its inappropriate recruitment has been associated with aberrant gene silencing in cancer. Sin3A/B are highly related, large, multidomian proteins that interact with a wide variety of transcription factors and corepressor components, andwe examined whether disruption of the function of a specific domain could lead to epigenetic reprogramming and derepression of specific subsets of genes. To this end, we selected the Sin3A/B-paired amphipathic α-helices (PAH2) domain based on its established role in mediating the effects of a relatively small number of transcription factors containing a PAH2-binding motif known as the Sin3 interaction domain (SID). Here, we show that in both human and mouse breast cancer cells, the targeted disruption of Sin3 function by introduction of a SID decoy that interferes with PAH2 binding to SID-containing partner proteins reverted the silencing of genes involved in cell growth and differentiation. In particular, the SID decoy led to epigenetic reprogramming and reexpression of the important breast cancer-associated silenced genes encoding E-cadherin, estrogen receptor α, and retinoic acid receptor β and impaired tumor growth in vivo. Interestingly, the SID decoy was effective in the triple-negative M.D. Anderson-Metastatic Breast-231 (MDA-MB-231) breast cancer cell line, restoring sensitivity to 17β-estradiol, tamoxifen, and retinoids. Therefore, the development of small molecules that can block interactions between PAH2 and SID-containing proteins offers a targeted epigenetic approach for treating this type of breast cancer that may also have wider therapeutic implications.

KW - E-cadherin

KW - Estrogen receptor

KW - Sin3 interaction domain

KW - Triple-negative

UR - http://www.scopus.com/inward/record.url?scp=77955377644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955377644&partnerID=8YFLogxK

U2 - 10.1073/pnas.1006737107

DO - 10.1073/pnas.1006737107

M3 - Article

C2 - 20547842

AN - SCOPUS:77955377644

VL - 107

SP - 11811

EP - 11816

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 26

ER -